{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,30]],"date-time":"2025-11-30T13:51:54Z","timestamp":1764510714349},"reference-count":38,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,8,18]]},"DOI":"10.7759\/cureus.9842","type":"journal-article","created":{"date-parts":[[2020,8,18]],"date-time":"2020-08-18T17:15:42Z","timestamp":1597770942000},"source":"Crossref","is-referenced-by-count":9,"title":["Association of Arrhythmias in Cardiac Amyloidosis and Cardiac Sarcoidosis"],"prefix":"10.7759","author":[{"given":"Ibtisam","family":"Ashraf","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mercedes Maria","family":"Peck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruchira","family":"Maram","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alaa","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diego","family":"Ochoa Crespo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gurleen","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bilal Haider","family":"Malik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.118.005407","article-title":"Epidemiology of cardiac amyloidosis-associated heart failure hospitalizations among fee-for-service Medicare beneficiaries in the United States","volume":"12","author":"Gilstrap LG","year":"2019","unstructured":"Gilstrap LG, Dominici F, Wang Y, et al.. Epidemiology of cardiac amyloidosis-associated heart failure hospitalizations among fee-for-service Medicare beneficiaries in the United States. Circ Heart Fail. 2019, 12:005407. 10.1161\/CIRCHEARTFAILURE.118.005407","journal-title":"Circ Heart Fail"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.4070\/kcj.2018.0432","article-title":"Management of arrhythmias associated with cardiac sarcoidosis","volume":"49","author":"Yada H","year":"2019","unstructured":"Yada H, Soejima K. Management of arrhythmias associated with cardiac sarcoidosis. Korean Circ J. 2019, 49:119-33. 10.4070\/kcj.2018.0432","journal-title":"Korean Circ J"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.acvd.2013.06.051","article-title":"Cardiac amyloidosis: updates in diagnosis and management","volume":"106","author":"Mohty D","year":"2013","unstructured":"Mohty D, Damy T, Cosnay P, Echahidi N, Casset-Senon D, Virot P, Jaccard A. Cardiac amyloidosis: updates in diagnosis and management. Arch Cardiovasc Dis. 2013, 106:528-40. 10.1016\/j.acvd.2013.06.051","journal-title":"Arch Cardiovasc Dis"},{"key":"ref4","article-title":"Sarcoidosis: genes and microbes--soil or seed","volume":"18","author":"McGrath DS","year":"2001","unstructured":"McGrath DS, Goh N, Foley PJ, du Bois RM. Sarcoidosis: genes and microbes--soil or seed. Sarcoidosis Vasc Diffuse Lung Dis. 2001, 18:149-64.","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.19102\/icrm.2018.090301","article-title":"Arrhythmias in cardiac amyloidosis","volume":"9","author":"John RM","year":"2018","unstructured":"John RM. Arrhythmias in cardiac amyloidosis. J Innov Card Rhythm Manag. 2018, 9:3051-7. 10.19102\/icrm.2018.090301","journal-title":"J Innov Card Rhythm Manag"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.114.011522","article-title":"Cardiac sarcoidosis: epidemiology, characteristics, and outcome over 25 years in a nationwide study","volume":"131","author":"Kandolin R","year":"2015","unstructured":"Kandolin R, Lehtonen J, Airaksinen J, et al.. Cardiac sarcoidosis: epidemiology, characteristics, and outcome over 25 years in a nationwide study. Circulation. 2015, 131:624-32. 10.1161\/CIRCULATIONAHA.114.011522","journal-title":"Circulation"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.21037\/atm.2018.07.33","article-title":"The burden of cardiac arrhythmias in sarcoidosis: a population-based inpatient analysis","volume":"6","author":"Desai R","year":"2018","unstructured":"Desai R, Kakumani K, Fong HK, et al.. The burden of cardiac arrhythmias in sarcoidosis: a population-based inpatient analysis. Ann Transl Med. 2018, 6:330. 10.21037\/atm.2018.07.33","journal-title":"Ann Transl Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/jce.12123","article-title":"Implantable cardioverter defibrillators in patients with cardiac amyloidosis","volume":"24","author":"Lin G","year":"2013","unstructured":"Lin G, Dispenzieri A, Kyle R, Grogan M, Brady PA. Implantable cardioverter defibrillators in patients with cardiac amyloidosis. J Cardiovasc Electrophysiol. 2013, 24:793-8. 10.1111\/jce.12123","journal-title":"J Cardiovasc Electrophysiol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1002\/ehf2.12602","article-title":"Stroke risk and atrial mechanical dysfunction in cardiac amyloidosis","volume":"7","author":"Ballantyne B","year":"2020","unstructured":"Ballantyne B, Manian U, Sheyin O, Davey R, De S. Stroke risk and atrial mechanical dysfunction in cardiac amyloidosis. ESC Heart Fail. 2020, 7:705-7. 10.1002\/ehf2.12602","journal-title":"ESC Heart Fail"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.104.489187","article-title":"Diagnosis and management of the cardiac amyloidoses","volume":"112","author":"Falk RH","year":"2005","unstructured":"Falk RH. Diagnosis and management of the cardiac amyloidoses. Circulation. 2005, 112:2047-60. 10.1161\/CIRCULATIONAHA.104.489187","journal-title":"Circulation"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.0000126569.75419.74","article-title":"Human amyloidogenic light chains directly impair cardiomyocyte function through an increase in cellular oxidant stress","volume":"94","author":"Brenner DA","year":"2004","unstructured":"Brenner DA, Jain M, Pimentel DR, et al.. Human amyloidogenic light chains directly impair cardiomyocyte function through an increase in cellular oxidant stress. Circ Res. 2004, 94:1008-10. 10.1161\/01.RES.0000126569.75419.74","journal-title":"Circ Res"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchf.2014.03.009","article-title":"Coronary microvascular dysfunction is related to abnormalities in myocardial structure and function in cardiac amyloidosis","volume":"2","author":"Dorbala S","year":"2014","unstructured":"Dorbala S, Vangala D, Bruyere J, et al.. Coronary microvascular dysfunction is related to abnormalities in myocardial structure and function in cardiac amyloidosis. JACC Heart Fail. 2014, 2:358-67. 10.1016\/j.jchf.2014.03.009","journal-title":"JACC Heart Fail"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1111\/j.1699-0463.1983.tb02765.x","article-title":"The cardiac atrioventricular conduction system in familial amyloidosis with polyneuropathy. A clinicopathologic study of six cases from northern Sweden","volume":"91","author":"Eriksson A","year":"1983","unstructured":"Eriksson A, Eriksson P, Olofsson B-O, Thorneli L-E. The cardiac atrioventricular conduction system in familial amyloidosis with polyneuropathy. A clinicopathologic study of six cases from northern Sweden. Acta Pathol Microbiol Immunol Scand [A]. 1983, 91:343-9. 10.1111\/j.1699-0463.1983.tb02765.x","journal-title":"Acta Pathol Microbiol Immunol Scand [A]"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/BF00695078","article-title":"The sinoatrial node in familial amyloidosis with polyneuropathy. A clinico-pathological study of nine cases from northern Sweden","volume":"402","author":"Eriksson A","year":"1984","unstructured":"Eriksson A, Eriksson P, Olofsson B-O, Thornell L-E. The sinoatrial node in familial amyloidosis with polyneuropathy. A clinico-pathological study of nine cases from northern Sweden. Virchows Arch (Pathol Anat). 1984, 402:239-46. 10.1007\/BF00695078","journal-title":"Virchows Arch (Pathol Anat)"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2009.12.040","article-title":"Infiltrative cardiovascular diseases: cardiomyopathies that look alike","volume":"55","author":"Seward JB","year":"2010","unstructured":"Seward JB, Casaclang-Verzosa G. Infiltrative cardiovascular diseases: cardiomyopathies that look alike. J Am Coll Cardiol. 2010, 55:1769-79. 10.1016\/j.jacc.2009.12.040","journal-title":"J Am Coll Cardiol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2015.05.021","article-title":"Characterization of cardiac amyloidosis by atrial late gadolinium enhancement using contrast-enhanced cardiac magnetic resonance imaging and correlation with left atrial conduit and contractile function","volume":"116","author":"Kwong RY","year":"2015","unstructured":"Kwong RY, Heydari B, Abbasi S, et al.. Characterization of cardiac amyloidosis by atrial late gadolinium enhancement using contrast-enhanced cardiac magnetic resonance imaging and correlation with left atrial conduit and contractile function. Am J Cardiol. 2015, 116:622-9. 10.1016\/j.amjcard.2015.05.021","journal-title":"Am J Cardiol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrthm.2015.09.016","article-title":"Electrophysiologic assessment of conduction abnormalities and atrial arrhythmias associated with amyloid cardiomyopathy","volume":"13","author":"Barbhaiya CR","year":"2016","unstructured":"Barbhaiya CR, Kumar S, Baldinger SH, et al.. Electrophysiologic assessment of conduction abnormalities and atrial arrhythmias associated with amyloid cardiomyopathy. Heart Rhythm. 2016, 13:383-90. 10.1016\/j.hrthm.2015.09.016","journal-title":"Heart Rhythm"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3109\/13506129.2010.483114","article-title":"Heart complications in familial transthyretin amyloidosis: impact of age and gender","volume":"17","author":"H\u00f6rnsten R","year":"2010","unstructured":"H\u00f6rnsten R, Pennlert J, Wiklund U, Lindqvist P, Jensen SM, Suhr OB. Heart complications in familial transthyretin amyloidosis: impact of age and gender. Amyloid. 2010, 17:63-8. 10.3109\/13506129.2010.483114","journal-title":"Amyloid"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1378\/chest.11-3214","article-title":"Supraventricular arrhythmias in patients with cardiac sarcoidosis prevalence, predictors, and clinical implications","volume":"143","author":"Viles-Gonzalez JF","year":"2013","unstructured":"Viles-Gonzalez JF, Pastori L, Fischer A, Wisnivesky JP, Goldman MG, Mehta D. Supraventricular arrhythmias in patients with cardiac sarcoidosis prevalence, predictors, and clinical implications. Chest. 2013, 143:1085-90. 10.1378\/chest.11-3214","journal-title":"Chest"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2014.01.434","article-title":"Cardiac sarcoidosis detected by late gadolinium enhancement and prevalence of atrial arrhythmias","volume":"113","author":"Cain MA","year":"2014","unstructured":"Cain MA, Metzl MD, Patel AR, et al.. Cardiac sarcoidosis detected by late gadolinium enhancement and prevalence of atrial arrhythmias. Am J Cardiol. 2014, 113:1556-60. 10.1016\/j.amjcard.2014.01.434","journal-title":"Am J Cardiol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(77)90121-8","article-title":"Sarcoidosis of the heart. A clinicopathologic study of 35 necropsy patients (group I) and review of 78 previously described necropsy patients (group II)","volume":"63","author":"Roberts WC","year":"1977","unstructured":"Roberts WC, McAllister HA Jr, Ferrans VJ. Sarcoidosis of the heart. A clinicopathologic study of 35 necropsy patients (group I) and review of 78 previously described necropsy patients (group II). Am J Med. 1977, 63:86-108. 10.1016\/0002-9343(77)90121-8","journal-title":"Am J Med"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.107.697763","article-title":"Intracardiac thrombosis and embolism in patients with cardiac amyloidosis","volume":"116","author":"Feng D","year":"2007","unstructured":"Feng D, Edwards WD, Oh JK, et al.. Intracardiac thrombosis and embolism in patients with cardiac amyloidosis. Circulation. 2007, 116:2420-6. 10.1161\/CIRCULATIONAHA.107.697763","journal-title":"Circulation"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.108.785014","article-title":"Intracardiac thrombosis and anticoagulation therapy in cardiac amyloidosis","volume":"119","author":"Feng D","year":"2009","unstructured":"Feng D, Syed IS, Martinez M, et al.. Intracardiac thrombosis and anticoagulation therapy in cardiac amyloidosis. Circulation. 2009, 119:2490-7. 10.1161\/CIRCULATIONAHA.108.785014","journal-title":"Circulation"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2019.02.078","article-title":"Predicting the unpredictable: how to score the risk of stroke in cardiac amyloidosis","volume":"73","author":"Russo D","year":"2019","unstructured":"Russo D, Limite LR, Arcari L, Autore C, Musumeci MB. Predicting the unpredictable: how to score the risk of stroke in cardiac amyloidosis. J Am Coll Cardiol. 2019, 73:2910-1. 10.1016\/j.jacc.2019.02.078","journal-title":"J Am Coll Cardiol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/91.2.141","article-title":"The clinical features of immunoglobulin light-chain (AL) amyloidosis with heart involvement","volume":"91","author":"Dubrey SW","year":"1998","unstructured":"Dubrey SW, Cha K, Anderson J, et al.. The clinical features of immunoglobulin light-chain (AL) amyloidosis with heart involvement. QJM. 1998, 91:141-57. 10.1093\/qjmed\/91.2.141","journal-title":"QJM"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehu506","article-title":"A study of implanted cardiac rhythm recorders in advanced cardiac AL amyloidosis","volume":"36","author":"Sayed RH","year":"2015","unstructured":"Sayed RH, Rogers D, Khan F, et al.. A study of implanted cardiac rhythm recorders in advanced cardiac AL amyloidosis. Eur Heart J. 2015, 36:1098-105. 10.1093\/eurheartj\/ehu506","journal-title":"Eur Heart J"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1111\/j.1540-8167.2005.00321.x","article-title":"Catheter ablation of ventricular fibrillation storm in patients with infiltrative amyloidosis of the heart","volume":"17","author":"Mlcochova H","year":"2006","unstructured":"Mlcochova H, Saliba WI, Burkhardt DJ, et al.. Catheter ablation of ventricular fibrillation storm in patients with infiltrative amyloidosis of the heart. J Cardiovasc Electrophysiol. 2006, 17:426-30. 10.1111\/j.1540-8167.2005.00321.x","journal-title":"J Cardiovasc Electrophysiol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCEP.114.002145","article-title":"Ventricular tachycardia in cardiac sarcoidosis: characterization of ventricular substrate and outcomes of catheter ablation","volume":"8","author":"Kumar S","year":"2015","unstructured":"Kumar S, Barbhaiya C, Nagashima K, et al.. Ventricular tachycardia in cardiac sarcoidosis: characterization of ventricular substrate and outcomes of catheter ablation. Circ Arrhythm Electrophysiol. 2015, 8:87-93. 10.1161\/CIRCEP.114.002145","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCEP.113.000734","article-title":"Systematic treatment approach to ventricular tachycardia in cardiac sarcoidosis","volume":"7","author":"Naruse Y","year":"2014","unstructured":"Naruse Y, Sekiguchi Y, Nogami A, et al.. Systematic treatment approach to ventricular tachycardia in cardiac sarcoidosis. Circ Arrhythm Electrophysiol. 2014, 7:407-13. 10.1161\/CIRCEP.113.000734","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.119.012097","article-title":"Noninvasive mapping of the electrophysiological substrate in cardiac amyloidosis and its relationship to structural abnormalities","volume":"8","author":"Orini M","year":"2019","unstructured":"Orini M, Graham AJ, Martinez-Naharro A, et al.. Noninvasive mapping of the electrophysiological substrate in cardiac amyloidosis and its relationship to structural abnormalities. J Am Heart Assoc. 2019, 8:012097. 10.1161\/JAHA.119.012097","journal-title":"J Am Heart Assoc"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1016\/s0735-1097(97)00267-2","article-title":"Electrophysiologic abnormalities in AL (primary) amyloidosis with cardiac involvement","volume":"30","author":"Reisinger J","year":"1997","unstructured":"Reisinger J, Dubrey SW, Lavalley M, Skinner M, Falk RH. Electrophysiologic abnormalities in AL (primary) amyloidosis with cardiac involvement. J Am Coll Cardiol. 1997, 30:1046-51. 10.1016\/s0735-1097(97)00267-2","journal-title":"J Am Coll Cardiol"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(77)90870-1","article-title":"The conduction system in cardiac amyloidosis. Clinical and pathologic features of 23 patients","volume":"62","author":"Ridolfi RL","year":"1977","unstructured":"Ridolfi RL, Bulkley BH, Hutchins GM. The conduction system in cardiac amyloidosis. Clinical and pathologic features of 23 patients. Am J Med. 1977, 62:677-86. 10.1016\/0002-9343(77)90870-1","journal-title":"Am J Med"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1111\/jce.12401","article-title":"Atrioventricular block as the initial manifestation of cardiac sarcoidosis in middle-aged adults","volume":"25","author":"Nery PB","year":"2014","unstructured":"Nery PB, Beanlands RS, Nair GM, et al.. Atrioventricular block as the initial manifestation of cardiac sarcoidosis in middle-aged adults. J Cardiovasc Electrophysiol. 2014, 25:875-81. 10.1111\/jce.12401","journal-title":"J Cardiovasc Electrophysiol"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1016\/j.cjca.2013.02.004","article-title":"Corticosteroid therapy for cardiac sarcoidosis: a systematic review","volume":"29","author":"Sadek MM","year":"2013","unstructured":"Sadek MM, Yung D, Birnie DH, Beanlands RS, Nery PB. Corticosteroid therapy for cardiac sarcoidosis: a systematic review. Can J Cardiol. 2013, 29:1034-41. 10.1016\/j.cjca.2013.02.004","journal-title":"Can J Cardiol"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2016.10.101","article-title":"Impact of early initiation of corticosteroid therapy on cardiac function and rhythm in patients with cardiac sarcoidosis","volume":"227","author":"Padala SK","year":"2017","unstructured":"Padala SK, Peaslee S, Sidhu MS, Steckman DA, Judson MA. Impact of early initiation of corticosteroid therapy on cardiac function and rhythm in patients with cardiac sarcoidosis. Int J Cardiol. 2017, 227:565-70. 10.1016\/j.ijcard.2016.10.101","journal-title":"Int J Cardiol"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1111\/jce.12424","article-title":"Catheter ablation of atrial arrhythmias in cardiac sarcoidosis","volume":"25","author":"Willner JM","year":"2014","unstructured":"Willner JM, Viles-Gonzalez JF, Coffey JO, Morgenthau AS, Mehta D. Catheter ablation of atrial arrhythmias in cardiac sarcoidosis. J Cardiovasc Electrophysiol. 2014, 25:958-63. 10.1111\/jce.12424","journal-title":"J Cardiovasc Electrophysiol"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1111\/jce.12424","article-title":"Catheter ablation for ventricular tachycardia in patients with cardiac sarcoidosis: a systematic review","volume":"20","author":"Papageorgiou N","year":"2018","unstructured":"Papageorgiou N, Provid\u00eancia R, Bronis K, et al.. Catheter ablation for ventricular tachycardia in patients with cardiac sarcoidosis: a systematic review. Europace. 2018, 20:682-91. 10.1111\/jce.12424","journal-title":"Europace"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrthm.2014.03.043","article-title":"HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis","volume":"11","author":"Birnie DH","year":"2014","unstructured":"Birnie DH, Sauer WH, Bogun F, et al.. HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis. Heart Rhythm. 2014, 11:1305-23. 10.1016\/j.hrthm.2014.03.043","journal-title":"Heart Rhythm"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/38723-association-of-arrhythmias-in-cardiac-amyloidosis-and-cardiac-sarcoidosis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:25:07Z","timestamp":1707506707000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/38723-association-of-arrhythmias-in-cardiac-amyloidosis-and-cardiac-sarcoidosis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,18]]},"references-count":38,"URL":"https:\/\/doi.org\/10.7759\/cureus.9842","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8,18]]}}}